Study of OSI-211 vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer
The purpose of this study is to estimate the efficacy and safety of OSI-211 and topotecan in patients with relapsed epithelial ovarian cancer.
Ovarian Neoplasms
DRUG: OSI-211 (Liposomal Lurtotecan)
The purpose of this study is to estimate the efficacy and safety of OSI-211 and topotecan in patients with relapsed epithelial ovarian cancer.